These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20595388)

  • 41. The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.
    Zhao J; O'Connor T; Vassar R
    J Neuroinflammation; 2011 Nov; 8():150. PubMed ID: 22047170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease.
    Sadleir KR; Popovic J; Vassar R
    J Biol Chem; 2018 Nov; 293(48):18434-18443. PubMed ID: 30315100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
    Devi L; Ohno M
    Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.
    Paris D; Ganey NJ; Laporte V; Patel NS; Beaulieu-Abdelahad D; Bachmeier C; March A; Ait-Ghezala G; Mullan MJ
    J Neuroinflammation; 2010 Mar; 7():17. PubMed ID: 20211007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques.
    Kandalepas PC; Sadleir KR; Eimer WA; Zhao J; Nicholson DA; Vassar R
    Acta Neuropathol; 2013 Sep; 126(3):329-52. PubMed ID: 23820808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BACE1: the beta-secretase enzyme in Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethanol Alters APP Processing and Aggravates Alzheimer-Associated Phenotypes.
    Huang D; Yu M; Yang S; Lou D; Zhou W; Zheng L; Wang Z; Cai F; Zhou W; Li T; Song W
    Mol Neurobiol; 2018 Jun; 55(6):5006-5018. PubMed ID: 28799137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
    Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
    Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deposition of BACE-1 Protein in the Brains of APP/PS1 Double Transgenic Mice.
    Luo G; Xu H; Huang Y; Mo D; Song L; Jia B; Wang B; Jin Z; Miao Z
    Biomed Res Int; 2016; 2016():8380618. PubMed ID: 27294139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1.
    Johnson ECB; Ho K; Yu GQ; Das M; Sanchez PE; Djukic B; Lopez I; Yu X; Gill M; Zhang W; Paz JT; Palop JJ; Mucke L
    Mol Neurodegener; 2020 Sep; 15(1):53. PubMed ID: 32921309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electroacupuncture Mitigates Hippocampal Cognitive Impairments by Reducing BACE1 Deposition and Activating PKA in APP/PS1 Double Transgenic Mice.
    Tang Y; Shao S; Guo Y; Zhou Y; Cao J; Xu A; Wu J; Li Z; Xiang D
    Neural Plast; 2019; 2019():2823679. PubMed ID: 31223308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer's disease mouse model.
    Shi Z; Hong Y; Zhang K; Wang J; Zheng L; Zhang Z; Hu Z; Han X; Han Y; Chen T; Yao Q; Cui H; Hong W
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2398-2407. PubMed ID: 28502705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treadmill exercise decreases β-amyloid burden in APP/PS1 transgenic mice involving regulation of the unfolded protein response.
    Xia J; Li B; Yin L; Zhao N; Yan Q; Xu B
    Neurosci Lett; 2019 Jun; 703():125-131. PubMed ID: 30905823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels.
    Deng QS; Dong XY; Wu H; Wang W; Wang ZT; Zhu JW; Liu CF; Jia WQ; Zhang Y; Schachner M; Ma QH; Xu RX
    Neuropsychopharmacology; 2016 Jan; 41(2):440-53. PubMed ID: 26062786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42.
    Buggia-Prevot V; Sevalle J; Rossner S; Checler F
    J Biol Chem; 2008 Apr; 283(15):10037-47. PubMed ID: 18263584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
    Oulès B; Del Prete D; Greco B; Zhang X; Lauritzen I; Sevalle J; Moreno S; Paterlini-Bréchot P; Trebak M; Checler F; Benfenati F; Chami M
    J Neurosci; 2012 Aug; 32(34):11820-34. PubMed ID: 22915123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of receptor tyrosine kinase Tyro3 in amyloidogenic APP processing and β-amyloid deposition in Alzheimer's disease models.
    Zheng Y; Wang Q; Xiao B; Lu Q; Wang Y; Wang X
    PLoS One; 2012; 7(6):e39035. PubMed ID: 22701746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.